To explore, understand, and leverage the scientific basis of the roles of sex and gender in Alzheimer’s disease to inform prevention and treatment, providing guidance for research, clinical trials, and policy.
- Pauline Maki, PhD, University of Illinois – Chicago (Network Chair)
- Michelle Mielke, PhD, Mayo Clinic (Network Co-Chair)
- Neelum Aggarwal, MD, Rush University
- Lisa Barnes, PhD, Rush University
- Kejal Kantarci, MD, MS Mayo Clinic
- Elizabeth Mormino, PhD, Stanford University
- Haung Yu, PhD, Columbia University
- Jill Goldstein, PhD, Harvard Medical School
Rebecca Nebel, PhD
- Imaging The Effects Of Menopausal Hormone Therapy On The Brain. Dr. Kejal Kantarci, August 24, 2017.
- The Importance Of Revamping The Guidelines For Alzheimer’s Disease. Dr. Neelum T. Aggarwal, August 2, 2017.
- To Understand Sex Differences In Alzheimer’s Disease, We Need To Understand Risk Factors Across The Lifespan. Dr. Elizabeth Mormino, July 10, 2017.
- Menopause, Memory And Alzheimer’s Disease. Dr. Pauline Maki, June 7, 2017.
- Women And Alzheimer’s Disease: The Facts Behind The Headlines. Dr. Michelle M. Mielke, March 20, 2017.
“This unique network addresses aging and dementia, one of the most important issues facing modern societies and it does so in the context of sex differences and how they are manifested across the life course. This network fills an important gap, as no other group is likely to do this.”
– Bruce McEwen, PhD, Alfred E. Mirsky professor of neuroscience at the Rockefeller University, director of the Harold and Margaret Milliken Hatch Laboratory of Neuroendocrinology, member of the SWHR Board of Directors, & member of the SWHR Interdisciplinary Network on Alzheimer’s Disease
Sponsorship of this network does not imply agreement with any content and/or comments presented by the members during network proceedings.